Certain safety net hospitals are charging insurers an average of 3.8 times more than the acquisition costs for oncology drugs, although depending on the drug, the markup can be much higher — up to 11 times the purchase price, a new report has found.
Report claims 340B hospitals are leveraging discounts to increase profits from cancer drugs
